 <h1>Tice BCG Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>bcg</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li>
<li>FAQ</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about bcg. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Tice BCG.</p><h2>In Summary</h2><p><b>Common side effects of Tice BCG include:</b> urinary tract infection, detrusor hyperreflexia of bladder, fever, hematuria, urinary frequency, urinary urgency, vomiting, chills, and malaise. <b>Other side effects include:</b> arthralgia.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to bcg: intravesical powder for suspension</i></p><h3>Warning</h3><p class="blackboxWarning-title">Intravesical route (Powder for Suspension; Powder for Solution)</p><p>Bacillus of Calmette and Guérin (BCG) infections have been reported in health care workers and in patients because of exposure to the vaccine during preparation and administration. Serious and fatal disseminated BCG infections have occurred with intravesical administration. Manifestations of disseminated infection may not develop for months or years after therapy as BCG may persist in the urinary tract for several months after treatment. TheraCys® and TICE® BCG contain live attenuated mycobacteria and because of the potential risk for transmission, they should be prepared, handled, and disposed of as a biohazard material.</p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, bcg (the active ingredient contained in Tice BCG) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>Check with your doctor as soon as possible if any of the following side effects occur while taking bcg:</p><p>
<i>More common</i>
</p><ul>
<li>Blood in urine</li>
<li>fever and chills</li>
<li>frequent urge to urinate</li>
<li>increased frequency of urination</li>
<li>joint pain</li>
<li>nausea and vomiting</li>
<li>painful urination (severe or continuing)</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Cough</li>
<li>skin rash</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of bcg may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Burning during first urination after treatment</li>
</ul><p>After you stop using this medicine, it may still produce some side effects that need attention. During this period of time, <b>Check with your doctor immediately</b> if you notice the following side effects:</p><ul>
<li>Cough</li>
<li>fever</li>
</ul><p>
<!-- end intravesical powder for suspension --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to bcg: intravesical powder for reconstitution, percutaneous powder for injection</i></p><h3>Genitourinary</h3><p><b>Very common</b> (10% or more): Dysuria (60%), increased urgency/frequency (40%), drug induced cystitis (30%), bacterial cystitis (27%), hematuria (27%), pollakiuria</p>
<p><b>Common</b> (1% to 10%): Urinary tract infection, urinary incontinence, micturition urgency, urine analysis abnormal, bladder cramps, hemorrhage cystitis, urinary retention</p>
<p><b>Uncommon</b> (0.1% to 1%): Bladder constriction, pyuria, ureteric obstruction</p>
<p><b>Rare</b> (0.01 to less than 0.1%): Epididymitis</p>
<p><b>Very rare</b> (less than 0.01%): Orchitis, balanoposthitis, prostatitis, vulvovaginal discomfort<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Malaise/fatigue/lethargy (19%), fever without infection (13%), influenza-like illness, pyrexia, rigors</p>
<p><b>Common</b> (1% to 10%): Chills</p>
<p><b>Very rare</b> (less than 0.01%): Reiter's syndrome, chest pain, peripheral edema, prostate specific antigen increased, weight decreased, BCG osteomyelitis<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Dizziness, vertigo</p>
<p><b>Very rare</b> (less than 0.01%): Dysesthesia, hyperesthesia, paresthesia, somnolence, headache<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Common</b> (1% to 10%): Anemia, leukopenia</p>
<p><b>Uncommon</b> (0.1% to 1%): Pancytopenia, thrombocytopenia</p>
<p><b>Very rare</b> (less than 0.01%): Lymphadenopathy </p>
<p><b>Frequency not reported</b>: Axillary or cervical lymphadenopathy, regional suppurative lymphadenitis<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Abdominal pain, nausea, vomiting, diarrhea</p>
<p><b>Very rare</b> (less than 0.01%): Dyspepsia, flatulence<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Infection</p>
<p><b>Uncommon</b> (0.1% to 1%): Tuberculosis infections</p>
<p><b>Very rare</b> (less than 0.01%): Disseminated BCG infection<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Skin rash, sweats</p>
<p><b>Uncommon</b> (0.1% to 1%): Rashes, eruptions and exanthema not otherwise classified</p>
<p><b>Very rare</b> (less than 0.01%): Lupus vulgaris, alopecia, hyperhidrosis, granuloma<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Pneumonitis</p>
<p><b>Rare</b> (0.01% to 0.1%): Cough</p>
<p><b>Very rare</b> (less than 0.01%): Pharyngitis, bronchitis, dyspnea, rhinitis<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Very rare</b> (less than 0.01%): Renal failure acute<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Arthralgia, arthritis, myalgia</p>
<p><b>Very rare</b> (less than 0.01%): Back pain<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Common</b> (1% to 10%): Allergic symptoms<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Uncommon</b> (0.1% to 1%): Hepatitis, hepatic enzyme increased<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very rare</b> (less than 0.01%): Hypotension<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Very rare</b> (less than 0.01%): Confusional state<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very rare</b> (less than 0.01%): Anorexia<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Very rare</b> (less than 0.01%): Conjunctivitis<sup>[Ref]</sup></p><h3>Local</h3><p><b>Frequency not reported</b>: Injection site reactions: Induration, pustule formation, ulceration, caseous lesions, purulent draining, tenderness, itching, papules<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_3">3. "Product Information. Tice BCG Vaccine (BCG (BCG vaccine))." Organon, West Orange, NJ. </p><p id="ref_4">4. "Product Information. BCG Vaccine (BCG)." Organon Pharmaceuticals, West Orange, NJ. </p></div>
<h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2>
<ul>
<li>Does the BCG vaccine for TB help with COVID-19 (coronavirus)?</li>
</ul>
<div class="more-resources" id="moreResources">
<h2>More about Tice BCG (bcg)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Drug class: miscellaneous antineoplastics</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Advanced Reading</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>TheraCys</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Urinary Tract Tumors</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to bcg: intravesical powder for reconstitution, percutaneous powder for injection</i></p><h3>Genitourinary</h3><p><b>Very common</b> (10% or more): Dysuria (60%), increased urgency/frequency (40%), drug induced cystitis (30%), bacterial cystitis (27%), hematuria (27%), pollakiuria</p><p><b>Common</b> (1% to 10%): Urinary tract infection, urinary incontinence, micturition urgency, urine analysis abnormal, bladder cramps, hemorrhage cystitis, urinary retention</p><p><b>Uncommon</b> (0.1% to 1%): Bladder constriction, pyuria, ureteric obstruction</p><p><b>Rare</b> (0.01 to less than 0.1%): Epididymitis</p><p><b>Very rare</b> (less than 0.01%): Orchitis, balanoposthitis, prostatitis, vulvovaginal discomfort<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Malaise/fatigue/lethargy (19%), fever without infection (13%), influenza-like illness, pyrexia, rigors</p><p><b>Common</b> (1% to 10%): Chills</p><p><b>Very rare</b> (less than 0.01%): Reiter's syndrome, chest pain, peripheral edema, prostate specific antigen increased, weight decreased, BCG osteomyelitis<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Dizziness, vertigo</p><p><b>Very rare</b> (less than 0.01%): Dysesthesia, hyperesthesia, paresthesia, somnolence, headache<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Common</b> (1% to 10%): Anemia, leukopenia</p><p><b>Uncommon</b> (0.1% to 1%): Pancytopenia, thrombocytopenia</p><p><b>Very rare</b> (less than 0.01%): Lymphadenopathy </p><p><b>Frequency not reported</b>: Axillary or cervical lymphadenopathy, regional suppurative lymphadenitis<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Abdominal pain, nausea, vomiting, diarrhea</p><p><b>Very rare</b> (less than 0.01%): Dyspepsia, flatulence<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Infection</p><p><b>Uncommon</b> (0.1% to 1%): Tuberculosis infections</p><p><b>Very rare</b> (less than 0.01%): Disseminated BCG infection<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Skin rash, sweats</p><p><b>Uncommon</b> (0.1% to 1%): Rashes, eruptions and exanthema not otherwise classified</p><p><b>Very rare</b> (less than 0.01%): Lupus vulgaris, alopecia, hyperhidrosis, granuloma<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Pneumonitis</p><p><b>Rare</b> (0.01% to 0.1%): Cough</p><p><b>Very rare</b> (less than 0.01%): Pharyngitis, bronchitis, dyspnea, rhinitis<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Very rare</b> (less than 0.01%): Renal failure acute<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Arthralgia, arthritis, myalgia</p><p><b>Very rare</b> (less than 0.01%): Back pain<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Common</b> (1% to 10%): Allergic symptoms<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Uncommon</b> (0.1% to 1%): Hepatitis, hepatic enzyme increased<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very rare</b> (less than 0.01%): Hypotension<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Very rare</b> (less than 0.01%): Confusional state<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very rare</b> (less than 0.01%): Anorexia<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Very rare</b> (less than 0.01%): Conjunctivitis<sup>[Ref]</sup></p><h3>Local</h3><p><b>Frequency not reported</b>: Injection site reactions: Induration, pustule formation, ulceration, caseous lesions, purulent draining, tenderness, itching, papules<sup>[Ref]</sup></p><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_3">3. "Product Information. Tice BCG Vaccine (BCG (BCG vaccine))." Organon, West Orange, NJ. </p><p id="ref_4">4. "Product Information. BCG Vaccine (BCG)." Organon Pharmaceuticals, West Orange, NJ. </p><h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2><ul>
<li>Does the BCG vaccine for TB help with COVID-19 (coronavirus)?</li>
</ul><h2>More about Tice BCG (bcg)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Drug class: miscellaneous antineoplastics</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Advanced Reading</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Urinary Tract Tumors</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>